Contact Us

*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 


Cell Phone 

Street Address 

Zip Code 



Date you started taking this drug:

Date you stopped taking this drug:

Age of patient when antidepressant(s) prescribed:

What condition was this medication prescribed to treat?

What additional medications were you taking at the time?

Did patient hurt themselves during or after taking the drug?

Did patient become violent during or after taking the drug?

Was suicide attempted?

Was hospitalization or institutionalization required after taking antidepressant(s)?

Did loved one commit suicide?

If patient did attempt or commit suicide, did patient ever attempt suicide previously?

If patient did commit suicide, what was the method of suicide?

Please describe violent or suicidal behavior:

If you ever tried to stop taking Paxil and experienced withdrawal, please describe the withdrawal side effects:

Please further describe side effects:

For verification purposes, please answer the below question:

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

GSK To Yield Over Cases of Suicide

Jun 21, 2003 | The Times

GLAXOSMITHKLINE, the world’s second largest drugs group, is expected to start making out-of-court settlements in America in cases where patients taking the antidepressant Paxil claim to have become suicidal.

The move comes after a case that went to court in Wyoming three years ago, where a jury awarded $8 million (£4.8 million) against GSK after a man taking Paxil sold in the UK as Seroxat killed his wife and other family members before committing suicide.It is thought that a dozen cases connecting Paxil with suicide have been brought in America.

The US Food and Drug Administration (FDA) said this week that it was “reviewing reports of a possible increased risk of suicidal thinking and suicide attempts in children†using Paxil, a drug which is not approved in the US for the treatment of under-18s.

The FDA, in a move that comes after the recent decision by UK drug regulators, said doctors should not prescribe Paxil to under-18s.

But the FDA said: “There is no evidence that Paxil is associated with an increased risk of suicidal thinking in adults.â€

GSK has also consistently said that there is no link between Paxil and suicide.

Last October GSK surprised the City by announcing a £145 million provision to cover previously unexpected legal costs.

Related articles
Parker Waichman Accolades And Reviews Best Lawyers Find Us On Avvo